A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
about
Macrophage function in obesity-induced inflammation and insulin resistance.Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3.The brown fat secretome: metabolic functions beyond thermogenesis.Knockout of STAT3 in skeletal muscle does not prevent high-fat diet-induced insulin resistance.Lack of Skeletal Muscle IL-6 Affects Pyruvate Dehydrogenase Activity at Rest and during Prolonged Exercise.Microglia activation due to obesity programs metabolic failure leading to type two diabetes.Regulation of metabolism by the innate immune system.Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.Targeting adipose tissue in the treatment of obesity-associated diabetes.Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell linesIKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.Adapting to obesity with adipose tissue inflammation.Lipotoxicity induces hepatic protein inclusions through TBK1-mediated p62/SQSTM1 phosphorylation.Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKK and Reveal Mechanisms for Selective InhibitionInhibition of TBK1/IKKε Promotes Regeneration of Pancreatic β-cellsRosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats
P2860
Q30235587-C3D584CE-D963-4FB3-89CD-FCBBEF72F0D3Q30253010-3EC08DDF-90A0-4B69-BEE8-11DB0C02604FQ35561612-77DF61C9-B346-4639-A35B-5DA00DDC769BQ35929484-CE43F16B-533E-43B9-B86B-BB7465EC7E99Q36057621-1AC29454-E51F-4683-8864-B113A67010BFQ37737776-F03AC40C-D4F2-42D7-8909-F35EE5138492Q38629225-E6F0AF12-D692-44A6-90B7-0BD6B44B1230Q38690898-254918FF-D019-4BA8-A8E8-2B174252531CQ38852204-6951CF86-C444-4110-B2C4-05C5AD7F69A7Q42358218-1D473F27-29FE-41F2-80A5-4637066F2B09Q42385508-936C07A5-A1DA-4AD4-9C44-619C7FA43E7DQ46611412-1BCF4633-65A0-4193-A2B7-C3CE13BB8D08Q47281872-85ED48E8-D014-48C5-86BE-605A5C07A563Q57143759-BFBDF52F-7CCA-4E2F-B157-D8AEFC19524CQ57805706-85AE5D4F-8A7F-4DFB-A807-7857D58F4780Q58700441-7549A283-99DA-4486-8B44-70AA1AC40DEF
P2860
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@ast
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@en
type
label
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@ast
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@en
prefLabel
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@ast
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@en
P2093
P2860
P50
P356
P1476
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.
@en
P2093
Adam Neidert
BreAnne Poirier
Carey N Lumeng
Christopher Liddle
Danielle M Krause
Evgenia Korytnaya
Louise Chang
Maeran Uhm
Maryam Ahmadian
Michael Downes
P2860
P2888
P356
10.1038/NCOMMS7047
P407
P577
2015-01-12T00:00:00Z